COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals

Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells. To design a recombinant protein-based COVID-19 vaccine, Vaxine pty Ltd used computer models of the spike protein and its human receptor, ACE2, to identify how the virus infects human cells. Base...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavda, Vivek P., Vora, Lalitkumar K., Vihol, Disha R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of Zhejiang Chinese Medical University. 2021
Materias:
Views on News
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351577/
http://dx.doi.org/10.1016/j.ccmp.2021.100004
_version_ 1783736003213656064
author Chavda, Vivek P.
Vora, Lalitkumar K.
Vihol, Disha R.
author_facet Chavda, Vivek P.
Vora, Lalitkumar K.
Vihol, Disha R.
author_sort Chavda, Vivek P.
collection PubMed
description Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells. To design a recombinant protein-based COVID-19 vaccine, Vaxine pty Ltd used computer models of the spike protein and its human receptor, ACE2, to identify how the virus infects human cells. Based on this, the COVAX-19Ⓡ vaccine is synthesized. It does reduce not only COVID-19 disease but also blocks virus shedding and transmission. Researchers are optimistic that this vaccine candidate could be clinically available soon with sufficient vaccine efficacy with a considerable amount of reduction in vaccination-related side effects.
format Online
Article
Text
id pubmed-8351577
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier B.V. on behalf of Zhejiang Chinese Medical University.
record_format MEDLINE/PubMed
spelling pubmed-83515772021-08-10 COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals Chavda, Vivek P. Vora, Lalitkumar K. Vihol, Disha R. Clinical Complementary Medicine and Pharmacology Views on News Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells. To design a recombinant protein-based COVID-19 vaccine, Vaxine pty Ltd used computer models of the spike protein and its human receptor, ACE2, to identify how the virus infects human cells. Based on this, the COVAX-19Ⓡ vaccine is synthesized. It does reduce not only COVID-19 disease but also blocks virus shedding and transmission. Researchers are optimistic that this vaccine candidate could be clinically available soon with sufficient vaccine efficacy with a considerable amount of reduction in vaccination-related side effects. Published by Elsevier B.V. on behalf of Zhejiang Chinese Medical University. 2021-12 2021-08-09 /pmc/articles/PMC8351577/ http://dx.doi.org/10.1016/j.ccmp.2021.100004 Text en © 2021 Published by Elsevier B.V. on behalf of Zhejiang Chinese Medical University. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Views on News
Chavda, Vivek P.
Vora, Lalitkumar K.
Vihol, Disha R.
COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
title COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
title_full COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
title_fullStr COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
title_full_unstemmed COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
title_short COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
title_sort covax-19ⓡ vaccine: completely blocks virus transmission to non-immune individuals
topic Views on News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351577/
http://dx.doi.org/10.1016/j.ccmp.2021.100004
work_keys_str_mv AT chavdavivekp covax19vaccinecompletelyblocksvirustransmissiontononimmuneindividuals
AT voralalitkumark covax19vaccinecompletelyblocksvirustransmissiontononimmuneindividuals
AT viholdishar covax19vaccinecompletelyblocksvirustransmissiontononimmuneindividuals

Ejemplares similares